Auray-Blais C - Search Results

1

Altered immune phenotypes in subjects with Fabry disease and responses to switching from agalsidase alfa to agalsidase beta.

Limgala RP, Jennelle T, Plassmeyer M, Boutin M, Lavoie P, Abaoui M, Auray-Blais C, Nedd K, Alpan O, Goker-Alpan O. Limgala RP, et al. Am J Transl Res. 2019 Mar 15;11(3):1683-1696. eCollection 2019. Am J Transl Res. 2019. PMID: 30972193 Free PMC article.

2

An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.

Auray-Blais C, Lavoie P, Zhang H, Gagnon R, Clarke JT, Maranda B, Young SP, An Y, Millington DS. Auray-Blais C, et al. Clin Chim Acta. 2012 Apr 11;413(7-8):771-8. doi: 10.1016/j.cca.2012.01.012. Epub 2012 Jan 20. Clin Chim Acta. 2012. PMID: 22285314

3

Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.

Auray-Blais C, Boutin M, Gagnon R, Dupont FO, Lavoie P, Clarke JT. Auray-Blais C, et al. Anal Chem. 2012 Mar 20;84(6):2745-53. doi: 10.1021/ac203433e. Epub 2012 Feb 28. Anal Chem. 2012. PMID: 22309310

4

Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic study.

Auray-Blais C, Boutin M. Auray-Blais C, et al. Curr Med Chem. 2012;19(19):3241-52. doi: 10.2174/092986712800784739. Curr Med Chem. 2012. PMID: 22612706

5

LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease.

Boutin M, Gagnon R, Lavoie P, Auray-Blais C. Boutin M, et al. Clin Chim Acta. 2012 Dec 24;414:273-80. doi: 10.1016/j.cca.2012.09.026. Epub 2012 Oct 2. Clin Chim Acta. 2012. PMID: 23041216

6

A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.

Dupont FO, Gagnon R, Boutin M, Auray-Blais C. Dupont FO, et al. Curr Med Chem. 2013;20(2):280-8. doi: 10.2174/092986713804806685. Curr Med Chem. 2013. PMID: 23092136

7

Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.

Lavoie P, Boutin M, Auray-Blais C. Lavoie P, et al. Anal Chem. 2013 Feb 5;85(3):1743-52. doi: 10.1021/ac303033v. Epub 2013 Jan 7. Anal Chem. 2013. PMID: 23248976 Clinical Trial.

8

A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients.

Manwaring V, Boutin M, Auray-Blais C. Manwaring V, et al. Anal Chem. 2013 Oct 1;85(19):9039-48. doi: 10.1021/ac401542k. Epub 2013 Sep 11. Anal Chem. 2013. PMID: 23968398

9

Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb₃-related analogues in Fabry disease.

Boutin M, Auray-Blais C. Boutin M, et al. Anal Chem. 2014 Apr 1;86(7):3476-83. doi: 10.1021/ac404000d. Epub 2014 Mar 17. Anal Chem. 2014. PMID: 24634980

10

High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.

Auray-Blais C, Maranda B, Lavoie P. Auray-Blais C, et al. Clin Chim Acta. 2014 Sep 25;436:249-55. doi: 10.1016/j.cca.2014.05.024. Epub 2014 Jun 6. Clin Chim Acta. 2014. PMID: 24909877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters